Echinacoside inhibits hepatocellular carcinoma progression by targeting the miR-30c-5p/FOXD1/KLF12 axis
These findings suggest that echinacoside could inhibit HCC progression, and the mechanism related to the enhanced miR-30c-5p/FOXD1/KLF12 axis. Moreover, the abovementioned intermediate molecules might serve as prospective biomarkers for HCC prognosis.
Authors
- Zhongchao Mai
- Juhua Zhuang
- Guoyu Wang (ORCID: https://orcid.org/0000-0001-7958-1992)
- Yang Han (ORCID: https://orcid.org/0000-0002-0034-5848)
- Wei Xia (ORCID: https://orcid.org/0000-0002-4171-5008)
- Ying Ye
Institutions
- Second Military Medical University (CN)
- Shanghai University of Traditional Chinese Medicine (CN)
- Seventh People's Hospital of Shanghai (CN)
- Shanghai Pudong New Area Gongli Hospital (CN)
Publication Details
- Journal
- Technology and Health Care
- Published
- 2024-09-13
- DOI
- https://doi.org/10.3233/thc-241449
- Citations
- 3
- Primary Topic
- Kruppel-like factors research
- Type
- article
- Field-Weighted Citation Impact
- 0.70